Targeting Axl-GAS6—a new option for tumor therapy
Tumor drug resistance is a major problem limiting the clinical efficacy of therapeutic drugs. Recently, an article published by a Spanish research ...
Read moreMATERIALIZE YOUR INNOVATION
Structure Aided design & Multiplex Screening
Drug development is full of unknowns. Don't let your reagents be one of them.
Featured product
Human Claudin 18.2 Protein-VLP (CLD-HE1822)
Featured article
Potential Immunotherapy Target TM4SF1
TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in the Tetraspanin superfamily. It was first identified in 1986. I...
Read more